{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T18:08:34Z","timestamp":1788718114425,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Ideas Grant"],"award-info":[{"award-number":["Ideas Grant"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Development Grant"],"award-info":[{"award-number":["Development Grant"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001202","name":"Gastroenterological Society of Australia","doi-asserted-by":"publisher","award":["Clinical Collaborative Grant"],"award-info":[{"award-number":["Clinical Collaborative Grant"]}],"id":[{"id":"10.13039\/501100001202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolic dysfunction-associated steatohepatitis (MASH) is the most prevalent cause of liver disease worldwide, with a single approved therapeutic. Previous research has shown that interleukin-22 (IL-22) can suppress \u03b2-cell stress, reduce local islet inflammation, restore appropriate insulin production, reverse hyperglycemia, and ameliorate insulin resistance in preclinical models of diabetes. In clinical trials long-acting forms of IL-22 have led to increased proliferation in the skin and intestine, where the IL-22RA1 receptor is highly expressed. To maximise beneficial effects whilst reducing the risk of epithelial proliferation and cancer, we designed short-acting IL-22-bispecific biologic drugs that successfully targeted the liver and pancreas. Here we show 10-fold lower doses of these bispecific biologics exceed the beneficial effects of native IL-22 in multiple preclinical models of MASH, without off-target effects. Treatment restores glycemic control, markedly reduces hepatic steatosis, inflammation, and fibrogenesis. These short-acting IL-22-bispecific targeted biologics are a promising new therapeutic approach for MASH.<\/jats:p>","DOI":"10.1038\/s41467-024-48317-x","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T10:02:04Z","timestamp":1716976924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9964-6244","authenticated-orcid":false,"given":"Haressh","family":"Sajiir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8116-8889","authenticated-orcid":false,"given":"Sahar","family":"Keshvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan Yau","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-7583","authenticated-orcid":false,"given":"Danielle J.","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-3608","authenticated-orcid":false,"given":"Frederik J.","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3693-9357","authenticated-orcid":false,"given":"Christian","family":"Fercher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breten","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-4828","authenticated-orcid":false,"given":"Ross T.","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3905-8627","authenticated-orcid":false,"given":"Md","family":"Moniruzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-6446","authenticated-orcid":false,"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Fotheringham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4623-9098","authenticated-orcid":false,"given":"Yong Hua","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle Louise","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Burr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-3670","authenticated-orcid":false,"given":"Tony","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-985X","authenticated-orcid":false,"given":"Jack","family":"Lockett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-6201","authenticated-orcid":false,"given":"Grant A.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0929-110X","authenticated-orcid":false,"given":"Graeme A.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes B.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8375-2675","authenticated-orcid":false,"given":"Michael A.","family":"McGuckin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-8628","authenticated-orcid":false,"given":"Sumaira Z.","family":"Hasnain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"key":"48317_CR1","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann. Hepatol. 29, 101133 (2023).","journal-title":"Ann. Hepatol."},{"key":"48317_CR2","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell, G. C. & Larter, C. Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99\u2013S112 (2006).","journal-title":"Hepatology"},{"key":"48317_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390, 497\u2013509 (2024).","journal-title":"N. Engl. J. Med."},{"key":"48317_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","volume":"18","author":"R Vuppalanchi","year":"2021","unstructured":"Vuppalanchi, R., Noureddin, M., Alkhouri, N. & Sanyal, A. J. Therapeutic pipeline in nonalcoholic steatohepatitis. Nat. Rev. Gastroenterol. Hepatol. 18, 373\u2013392 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"48317_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/nm.3705","volume":"20","author":"SZ Hasnain","year":"2014","unstructured":"Hasnain, S. Z. et al. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nat. Med 20, 1417\u20131426 (2014).","journal-title":"Nat. Med"},{"key":"48317_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep28990","volume":"6","author":"M Gulhane","year":"2016","unstructured":"Gulhane, M. et al. High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Sci. Rep. 6, 28990 (2016).","journal-title":"Sci. Rep."},{"key":"48317_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/imcb.12249","volume":"97","author":"SZ Hasnain","year":"2019","unstructured":"Hasnain, S. Z. & Begun, J. Interleukin-22: friend or foe? Immunol. Cell Biol. 97, 355\u2013357 (2019).","journal-title":"Immunol. Cell Biol."},{"key":"48317_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature13564","volume":"514","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514, 237\u2013241 (2014).","journal-title":"Nature"},{"key":"48317_CR9","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.3390\/ijms20143468","volume":"20","author":"M Moniruzzaman","year":"2019","unstructured":"Moniruzzaman, M., Wang, R., Jeet, V., McGuckin, M. A. & Hasnain, S. Z. Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1\/2 pathway. Int J. Mol. Sci. 20, 3468 (2019).","journal-title":"Int J. Mol. Sci."},{"key":"48317_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature16460","volume":"528","author":"CA Lindemans","year":"2015","unstructured":"Lindemans, C. A. et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528, 560\u2013564 (2015).","journal-title":"Nature"},{"key":"48317_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41423-018-0029-8","volume":"16","author":"KY Tang","year":"2019","unstructured":"Tang, K. Y. et al. Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects. Cell Mol. Immunol. 16, 473\u2013482 (2019).","journal-title":"Cell Mol. Immunol."},{"key":"48317_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.molmet.2019.07.008","volume":"28","author":"Z He","year":"2019","unstructured":"He, Z. et al. Direct and indirect effects of liraglutide on hypothalamic POMC and NPY\/AgRP neurons\u2014Implications for energy balance and glucose control. Mol. Metab. 28, 120\u2013134 (2019).","journal-title":"Mol. Metab."},{"key":"48317_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ijo.2015.145","volume":"40","author":"L Xiao","year":"2016","unstructured":"Xiao, L. et al. Large adipocytes function as antigen-presenting cells to activate CD4(+) T cells via upregulating MHCII in obesity. Int. J. Obes. 40, 112\u2013120 (2016).","journal-title":"Int. J. Obes."},{"key":"48317_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/hep.31046","volume":"72","author":"JP Arab","year":"2020","unstructured":"Arab, J. P. et al. An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis. Hepatology 72, 441\u2013453 (2020).","journal-title":"Hepatology"},{"key":"48317_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00125-022-05814-2","volume":"66","author":"N Brusco","year":"2023","unstructured":"Brusco, N. et al. Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes. Diabetologia 66, 354\u2013366 (2023).","journal-title":"Diabetologia"},{"key":"48317_CR16","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/JME-15-0232","volume":"56","author":"SZ Hasnain","year":"2016","unstructured":"Hasnain, S. Z., Prins, J. B. & McGuckin, M. A. Oxidative and endoplasmic reticulum stress in beta-cell dysfunction in diabetes. J. Mol. Endocrinol. 56, R33\u2013R54 (2016).","journal-title":"J. Mol. Endocrinol."},{"key":"48317_CR17","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/nm.3748","volume":"20","author":"E Dalmas","year":"2014","unstructured":"Dalmas, E. & Donath, M. Y. A role for interleukin-22 in the alleviation of metabolic syndrome. Nat. Med. 20, 1379\u20131381 (2014).","journal-title":"Nat. Med."},{"key":"48317_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.toxlet.2019.01.001","volume":"304","author":"L Sharma","year":"2019","unstructured":"Sharma, L., Gupta, D. & Abdullah, S. T. Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL\/6J mice: a novel eight weeks model of fibrosing NASH. Toxicol. Lett. 304, 21\u201329 (2019).","journal-title":"Toxicol. Lett."},{"key":"48317_CR19","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.25744","volume":"56","author":"X Kong","year":"2012","unstructured":"Kong, X. et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 56, 1150\u20131159 (2012).","journal-title":"Hepatology"},{"key":"48317_CR20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jhep.2021.02.002","volume":"74","author":"M Eslam","year":"2021","unstructured":"Eslam, M. & George, J. MAFLD: Now is the time to capitalize on the momentum. J. Hepatol. 74, 1262\u20131263 (2021).","journal-title":"J. Hepatol."},{"key":"48317_CR21","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/jcm10061161","volume":"10","author":"R Pais","year":"2021","unstructured":"Pais, R. & Maurel, T. Natural History of NAFLD. J. Clin. Med 10, 1161 (2021).","journal-title":"J. Clin. Med"},{"key":"48317_CR22","doi-asserted-by":"publisher","unstructured":"Sajiir, H. et al. Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-024-48320-2 (2024).","DOI":"10.1038\/s41467-024-48320-2"},{"key":"48317_CR23","doi-asserted-by":"publisher","first-page":"e23737","DOI":"10.1371\/journal.pone.0023737","volume":"6","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22. PLoS ONE 6, e23737 (2011).","journal-title":"PLoS ONE"},{"key":"48317_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3892\/etm.2021.10522","volume":"22","author":"Z Xing","year":"2021","unstructured":"Xing, Z., Wu, Y. & Liu, N. IL-22 alleviates the fibrosis of hepatic stellate cells via the inactivation of NLRP3 inflammasome signaling. Exp. Ther. Med. 22, 1088 (2021).","journal-title":"Exp. Ther. Med."},{"key":"48317_CR25","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","volume":"22","author":"HH Hansen","year":"2017","unstructured":"Hansen, H. H. et al. Mouse models of nonalcoholic steatohepatitis in preclinical drug development. Drug Discov. Today 22, 1707\u20131718 (2017).","journal-title":"Drug Discov. Today"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48317-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48317-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48317-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T10:04:02Z","timestamp":1716977042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48317-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["48317"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-48317-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,29]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.Z.H., M.A.M., and J.B.P. are inventors on a patent relating to IL-22 use in metabolic disease. The remaining authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4528"}}